Monica Hayhurst Bennett has joined the Genea Biocells team on July 11, 2016 as our new Director of Preclinical Research reporting to the General Manager. Dr. Bennett has over 9 years of translational research experience in the areas of stem cell biology, neuroscience, and muscle biology. Her biotechnology experience includes developing both protein and cellular therapeutics in degenerative diseases of skeletal muscle at Fate Therapeutics and leading research activities in the areas of neuroscience, metabolic and cardiovascular biology at Orexigen Therapeutics. Dr. Bennett received her Ph.D. from Stanford University with a focus on developmental neurobiology in the laboratory of Susan McConnell and completed her postdoctoral training with Lee Rubin at the Harvard Stem Cell Institute where she investigated the neurodegenerative condition Spinal Muscular Atrophy.
Please follow and like us: